Sylvia Mathews Burwell nominated as next US HHS Secretary as Sebelius quits

14 April 2014
kathleen-sebelius-big

On Friday in a Rose Garden ceremony, US President Barack Obama announced that Sylvia Mathews Burwell, the current director of the Office of Management and Budget, has been nominated to follow Kathleen Sebelius, who has resigned from the post, as Secretary of Health and Human Services.

Ms Sebelius (pictured), appointed HHS Secretary in April 2009, had faced calls for her resignation – primarily from Republican politicians who have criticized the Affordable Care Act, or “Obamacare” - over the flaw-filled launch of the Obamacare website.

One of her final acts as Secretary was to announce last Thursday that 7.5 million people had enrolled for insurance via exchanges set up by the government under the law – the biggest change to public health programs for almost 50 years. That level of enrolment marks a turnaround for Mr Obama after web site problems and other glitches marred the launch of insurance exchanges in October, delivering a blow to the administration and Democratic supporters of the law, commented the UK’s Financial Times.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical